The FDA announced on Aug. 27 that it had approved updated COVID-19 vaccines, but only for certain groups of people.

Fox News senior medical analyst Dr. Marc Siegel discusses RFK Jr.'s challenge of vaccine recommendations on 'Fox Report.'

To read yesterday’s edition of Five things for pharma marketers to know, click here.

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its Z-1018 vaccine to GSK's $4.5 billion blockbuster Shingrix, showing comparable efficacy but an edge for its shot on tolerability.

The AAP published its own vaccine schedule in a break from federal guidance. HHS secretary RFK Jr. took to social media to respond.

Patents are the principal form of IP protection for vaccines and medicines. They grant pharmaceutical companies the right to exclude others from making and selling their product.

A draft copy of the Make America Healthy Again Commission’s latest report, obtained by Politico, focuses on vaccine-related injuries and expediting access to investigational medicines for children—even though the FDA has recently rejected several of them.

This time of year always brings a familiar routine for Utah families, as kids head back to school and doctors prepare for the upcoming season. This year, things are a little different.

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure.

The Department of Health and Human Services (HHS) is relaunching a task force focused on the safety of childhood vaccines. | The Department of Health and Human Services is relaunching a task force focused on the safety of childhood vaccines.